Gadobutrol is a macrocyclic, gadolinium-based contrast agent used in magnetic resonance imaging (MRI) to enhance the visualization of tissues and vascular structures in the brain, spine, kidneys, and heart.… Read more





















Gadobutrol is a macrocyclic, gadolinium-based contrast agent used in magnetic resonance imaging (MRI) to enhance the visualization of tissues and vascular structures in the brain, spine, kidneys, and heart. This category provides essential reference standards for the Gadobutrol active pharmaceutical ingredient, alongside a comprehensive range of pharmacopeial and non-pharmacopeial impurities, metabolites like calcobutrol, and stable isotope labelled compounds. These high-quality materials are critical for pharmaceutical laboratories performing rigorous impurity profiling, method development, and quality control. By utilizing these specialized reference materials, researchers can accurately detect, quantify, and validate the presence of process-related impurities and degradants throughout the drug development lifecycle. These compounds are integral to maintaining regulatory compliance and ensuring the safety and efficacy of the final medicinal product in clinical applications.